Sign up for the QMED & MD+DI Daily newsletter.
Dexcom Breaks Ground on Ireland Manufacturing Facility
Its location, according to the company, has the potential to lower the cost of goods and improve sustainability in regards to transit time in Europe.
January 19, 2024
2 Min Read
martin-dm / iStock / Getty Images Plus via Getty Images
Dexcom, known for its continuous glucose monitoring devices, has officially broken ground on its new manufacturing facility based in Athenry, Galway, Ireland, bringing more than 1,000 jobs to the area. The jobs include support in finance, human resources, as well as a variety of engineering roles. With positions ranging from leadership to entrance level, Dexcom said it intends to link with local universities and neighboring communities, particularly focusing on engineering and quality assurance sources.
As the company’s first manufacturing facility in Europe, Dexcom said its location has the potential to lower the cost of goods and improve sustainability in regards to transit time. “This facility is strategically located in Europe, for Europe,” said Alex Moussa, senior vice president & general manager EMEA and LATAM at Dexcom, in a press release. “This development demonstrates our commitment to sustainable growth and operational excellence in EMEA, as well as to the people we serve. This is only the beginning; we’re truly excited for what’s to come.”
The new facility will, according to the company, have the capacity to produce millions of Dexcom real-time continuous glucose monitoring sensors each year.
The project is supported by the Irish Government through IDA Ireland, with minister of enterprise trade & employment, Simon Coveney, TD, calling it “not only a huge vote of confidence in Athenry [Galway] but in Ireland as a whole.”
Continuing, Dara Calleary TD, minister of state for trade promotion, digital, and company regulation, said, “Dexcom’s presence here in the West will not only contribute to the country’s economy, providing valuable employment at the site here in Galway, but also endorses Ireland’s status as a global hub of life sciences. The investment in Athenry to establish the first European manufacturing facility is a clear demonstration of Dexcom’s commitment to Galway.”
The company is the latest CGM manufacturer to break ground in the country. It was only last April that Abbott also began construction of a FreeStyle Libre manufacturing plant in Kilkenny, approximately two and a half hours south-east of Dexcom’s Galway location.
About the Author(s)
Managing Editor, MD+DI
Katie Hobbins is managing editor for MD+DI and joined the team in July 2022. She boasts multiple previous editorial roles in print and multimedia medical journalism, including dermatology, medical aesthetics, and pediatric medicine. She graduated from Cleveland State University in 2018 with a bachelor's degree in journalism and promotional communications. She enjoys yoga, hand embroidery, and anything DIY. You can reach her at [email protected].
You May Also Like
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read
Top 40 Medical Device CompaniesFeb 29, 2024|2 Min Read
2024 Planning Guide for Medical Manufacturing AutomationFeb 29, 2024|1 Min Read
Adverse Events Reported for Hologic BioZorb Marker, BioZorb LP MarkerFeb 28, 2024|2 Min Read